Article Details

Novartis' Sandoz targets biosimilar version of J&J drug in Samsung deal | Reuters

Retrieved on: 2023-09-11 15:46:54

Tags for this article:

Click the tags to see associated articles and topics

Novartis' Sandoz targets biosimilar version of J&J drug in Samsung deal | Reuters. View article details on HISWAI: https://www.reuters.com/business/healthcare-pharmaceuticals/sandoz-enters-commercialisation-agreement-with-samsung-bioepis-2023-09-11/

Excerpt

Samsung Electronics Co Ltd. Follow. Sandoz GmbH. Follow. Show more companies. FRANKFURT, Sept 11 (Reuters) - Novartis' (NOVN.

Article found on: www.reuters.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up